South African Propolis: Anti-Helicobacter pylori Activity, Chemistry, and Toxicity
View abstract on PubMed
Summary
This summary is machine-generated.South African propolis exhibits potent antimicrobial activity against Helicobacter pylori, a common gut pathogen. This natural bee product shows promise for treating H. pylori infections with no observed toxicity.
Area Of Science
- Pharmacology and Microbiology
- Natural Product Chemistry
Background
- Propolis, a bee-derived resin, is known for its antimicrobial properties.
- Helicobacter pylori is a significant gastrointestinal pathogen.
- The antimicrobial potential of South African propolis against H. pylori remained uninvestigated.
Purpose Of The Study
- To evaluate the antimicrobial activity of South African propolis extracts against H. pylori.
- To assess the toxicity of these propolis extracts.
- To identify key chemical compounds responsible for the observed anti-H. pylori activity.
Main Methods
- Collection and ethanolic extraction of 51 South African and 3 Brazilian propolis samples.
- Antimicrobial broth microdilution assay to determine minimum inhibitory concentrations (MICs) against clinical H. pylori strains.
- Brine shrimp lethality assay for toxicity assessment and ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) for chemical profiling.
Main Results
- 27 South African propolis extracts demonstrated superior antimicrobial activity against H. pylori compared to Brazilian samples (MIC ≤ 0.51 mg/mL).
- Pinocembrin, 3-O-acetylpinobanksin, and pinobanksin were identified as the most abundant compounds in active extracts.
- All tested propolis extracts were found to be non-toxic in the brine shrimp lethality assay (mortality < 50%).
Conclusions
- South African propolis possesses significant in vitro antimicrobial potential against Helicobacter pylori.
- Specific compounds like pinocembrin derivatives are likely responsible for the observed anti-H. pylori effects.
- Propolis represents a promising natural agent for the development of treatments for H. pylori infections.
Related Concept Videos
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...

